Genetic Correlates of Treatment Utilization for Alcohol Use Disorder: A Family‐Based and Polygenic Investigation
Alcohol, Clinical and Experimental Research · 2026-11 · 50 (11)
DOI: 10.1111/acer.70435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 01.11.2026. Verfasst von Kellyn M Spychala und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Washington University in Saint Louis, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Alcoholism, Multifactorial Inheritance, Patient Acceptance of Health Care. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NCATS NIH HHS, NIDA NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
The widespread prevalence of alcohol use disorder (AUD) and availability of treatments contrasts with limited treatment utilization. Here, in the Collaborative Studies on the Genetics of Alcoholism (COGA), we examined the extent to which genetic factors (i.e., family‐based heritability ( h 2 GCTA ), polygenic scores [PGS]) are associated with individual differences in AUD treatment utilization that could be leveraged to target intervention efforts.
Methods
Non‐proband COGA participants with a lifetime Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM‐5) AUD diagnosis, whose genomic ancestry resembled that of European (EUR‐like: N = 3148; 370 nuclear families; 222 extended family pedigrees) and African (AFR‐like: N = 962; 92 nuclear families; 79 extended family pedigrees) reference panels were selected for analyses. AUD treatment h 2 GCTA and associations with PGS (i.e., alcohol involvement, cigarette use, psychopathology, externalizing behavior, and cognition‐related) were estimated, along with between‐ and within‐family effects of the PGSs.
Results
AUD treatment was heritable ( h 2 GCTA = 0.36; SE = 0.06) and positively associated with PGS for problematic alcohol use, drinks/week, externalizing behavior, depression, anxiety and schizophrenia/bipolar (ORs > 1.12) while being negatively associated with education attainment (OR = 0.90) in the EUR‐like sample after accounting for AUD severity ( p FDR ≤ 0.04). When all significant PGSs were simultaneously included, only alcohol PGSs remained significant. There were no significant PGS associations in within‐family analyses. Despite a nominally significant positive association with cigarettes per day, no PGSs were associated with AUD treatment following FDR adjustment in the AFR‐like sample.
Conclusions
Genetic factors underlying alcohol use influence AUD treatment utilization, but this phenotype is largely not significantly associated with current estimates of polygenic scores for other complex traits; this suggests a potential unique genetic etiology requiring further investigation with a genome‐wide association study. The lack of significant within‐family PGS associations may have likely arisen from power reductions due to restricting the sample to full siblings. Together, these findings highlight potential facets influencing the underutilization of AUD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, School of Medicine, Washington University in Saint Louis, St. Louis, Missouri, USA.
- Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Division of Biology & Biomedical Sciences, Washington University in Saint Louis, St. Louis, Missouri, USA.
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Rutgers Addiction Research Center, Robert Wood Johnson Medical School Psychiatry, Rutgers University, New Brunswick, New Jersey, USA.
- Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.
ORCID-Profile: Kellyn M Spychala, Christina E Garasky, Margaret L Clapp Sullivan, Emma C Johnson, Dongbing Lai, Zeal Jinwala, Alex P Miller, Danielle M Dick, Jill A Rabinowitz, Sally I-Chun Kuo, John Nurnberger, Martin H Plawecki, Ashwini K Pandey, Grace Chan, Genevieve F Dash, Sivan Kinreich, Marc Schuckit, Fanghong Dong, Victor Hesselbrock, Kathleen K Bucholz, Vivia V McCutcheon, Ryan Bogdan
Förderung
- NIAAA NIH HHS
- NCATS NIH HHS
- NIDA NIH HHS
- NIMH NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Drug Abuse
- National Center for Advancing Translational Sciences
- National Institute of Mental Health
Zitieren
APA
Spychala, K. M., Garasky, C. E., Clapp Sullivan, M. L., Johnson, E. C., Kutzner, J., Lai, D., Jinwala, Z., Miller, A. P., Dick, D. M., Rabinowitz, J. A., Kuo, S. I., Nurnberger, J., Plawecki, M. H., Pandey, A. K., Chan, G., Dash, G. F., Kinreich, S., Schuckit, M., Dong, F., …, & Agrawal, A. (2026). Genetic Correlates of Treatment Utilization for Alcohol Use Disorder: A Family‐Based and Polygenic Investigation. Alcohol, Clinical and Experimental Research, 50(11). https://doi.org/10.1111/acer.70435
Vancouver
Spychala KM, Garasky CE, Clapp Sullivan ML, Johnson EC, Kutzner J, Lai D, et al. Genetic Correlates of Treatment Utilization for Alcohol Use Disorder: A Family‐Based and Polygenic Investigation. Alcohol, Clinical and Experimental Research. 2026;50(11). doi:10.1111/acer.70435
BibTeX
@article{Spychala2026,
author = {Spychala, Kellyn M and Garasky, Christina E and Clapp Sullivan, Margaret L and Johnson, Emma C and Kutzner, Jodi and Lai, Dongbing and Jinwala, Zeal and Miller, Alex P and Dick, Danielle M and Rabinowitz, Jill A and Kuo, Sally I-Chun and Nurnberger, John and Plawecki, Martin H and Pandey, Ashwini K and Chan, Grace and Dash, Genevieve F and Kinreich, Sivan and Schuckit, Marc and Dong, Fanghong and Hesselbrock, Victor and Porjesz, Bernice and Bucholz, Kathleen K and McCutcheon, Vivia V and Bogdan, Ryan and Agrawal, Arpana},
title = {Genetic Correlates of Treatment Utilization for Alcohol Use Disorder: A Family‐Based and Polygenic Investigation},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
volume = {50},
number = {11},
doi = {10.1111/acer.70435}
}
EUVIMED